gvtcx

NHS England Framework Agreement: Midlands and East (Tranche A)

NHS England Published 8 Sept 2017 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£163,000,000
Statuscomplete
Category (CPV) 33600000
RegionEast Midlands, West Midlands, East of England
Deadline10 Oct 2017
Contract start1 Mar 2018
Contract end29 Feb 2020
Procedureopen
SME suitableYes
OCIDocds-b5fd17-77d36d6b-c958-44c6-9099-935d56f82b4c

Awards (22)

This procurement was awarded to 22 suppliers. Values shown are per-award; the notice total is £163,000,000.

SupplierValueDateStatus
ABBVIE LTD shared £163,000,000 8 Jan 2018 active
ACTAVIS UK LIMITED shared £163,000,000 8 Jan 2018 active
ALLERGAN LIMITED shared £163,000,000 8 Jan 2018 active
AMGEN LIMITED shared £163,000,000 8 Jan 2018 active
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED shared £163,000,000 8 Jan 2018 active
CHUGAI PHARMA U.K. LTD. shared £163,000,000 8 Jan 2018 active
ELI LILLY AND COMPANY LIMITED shared £163,000,000 8 Jan 2018 active
FERRING PHARMACEUTICALS LIMITED shared £163,000,000 8 Jan 2018 active
GILEAD SCIENCES LTD shared £163,000,000 8 Jan 2018 active
IPSEN LIMITED shared £163,000,000 8 Jan 2018 active
JANSSEN-CILAG LIMITED shared £163,000,000 8 Jan 2018 active
MERCK SERONO LIMITED shared £163,000,000 8 Jan 2018 active
MERCK SHARP & DOHME LIMITED shared £163,000,000 8 Jan 2018 active
MERZ PHARMA UK LIMITED shared £163,000,000 8 Jan 2018 active
NOVO NORDISK LIMITED shared £163,000,000 8 Jan 2018 active
PFIZER LIMITED shared £163,000,000 8 Jan 2018 active
PHARMACOSMOS UK LIMITED shared £163,000,000 8 Jan 2018 active
ROCHE PRODUCTS LIMITED shared £163,000,000 8 Jan 2018 active
SANDOZ LIMITED shared £163,000,000 8 Jan 2018 active
TEVA UK LIMITED shared £163,000,000 8 Jan 2018 active
VIFOR PHARMA UK LIMITED shared £163,000,000 8 Jan 2018 active
VIIV HEALTHCARE LIMITED shared £163,000,000 8 Jan 2018 active

description

A framework is awarded for the supply of proprietary pharmaceuticals to participating Authorities in the NHS Region: Midlands and East. The period of the resulting framework is 01 March 2018 - 29 February 2020, with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.

The advertised awarding value of £163 million is the maximum value over the full potential 4 year period. The initial 2 year period of 1 March 2018 - 29 February 2020 therefore carries an awarding value of £81.5 million (£40.75 million per annum).

Additional information:

Attached is the model form framework agreement. All of the awarded frameworks were made on the basis of the model form framework agreement.

Redacted award schedules have been attached for each of the 22 awarded suppliers.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
27 Feb 2018 Award (award) · 29d7e659-9533-46be-a0f1-44eaac523dda-201976

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.